Literature DB >> 19836496

Adrenocortical cancer.

Melissa Wandoloski1, Kimberly J Bussey, Michael J Demeure.   

Abstract

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy causing up to 0.2% of all cancer deaths This article reviews the incidence, presentation, and pathology of ACC. Particular attention is paid to the molecular oncogenesis of this disease, and the surgical and therapeutic options available for its cure.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19836496     DOI： 10.1016/j.suc.2009.06.019

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  19 in total

1.  Surgery: Does laparoscopic adrenalectomy have a role in suspected ACC?

Authors:  Michael J Demeure
Journal:  Nat Rev Urol       Date:  2010-10       Impact factor: 14.432

2.  Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.

Authors:  Masha Livhits; Ning Li; Michael W Yeh; Avital Harari
Journal:  Surgery       Date:  2014-11-11       Impact factor: 3.982

3.  Operative management for recurrent and metastatic adrenocortical carcinoma.

Authors:  Nicole M Datrice; Russell C Langan; R Taylor Ripley; Clinton D Kemp; Seth M Steinberg; Bradford J Wood; Steven K Libutti; Tito Fojo; David S Schrump; Itzhak Avital
Journal:  J Surg Oncol       Date:  2011-12-20       Impact factor: 3.454

4.  Therapy of adrenocortical cancer: present and future.

Authors:  Daniela F Maluf; Brás H de Oliveira; Enzo Lalli
Journal:  Am J Cancer Res       Date:  2010-12-07       Impact factor: 6.166

5.  CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies.

Authors:  H M Zhang; N D Perrier; E G Grubbs; K Sircar; Z X Ye; J E Lee; C S Ng
Journal:  Clin Radiol       Date:  2011-07-23       Impact factor: 2.350

6.  Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.

Authors:  Barbra S Miller; Paul G Gauger; Gary D Hammer; Thomas J Giordano; Gerard M Doherty
Journal:  Langenbecks Arch Surg       Date:  2010-08-09       Impact factor: 3.445

7.  Integrated genomic characterization of adrenocortical carcinoma.

Authors:  Guillaume Assié; Eric Letouzé; Martin Fassnacht; Anne Jouinot; Windy Luscap; Olivia Barreau; Hanin Omeiri; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Nabila Elarouci; Silviu Sbiera; Matthias Kroiss; Bruno Allolio; Jens Waldmann; Marcus Quinkler; Massimo Mannelli; Franco Mantero; Thomas Papathomas; Ronald De Krijger; Antoine Tabarin; Véronique Kerlan; Eric Baudin; Frédérique Tissier; Bertrand Dousset; Lionel Groussin; Laurence Amar; Eric Clauser; Xavier Bertagna; Bruno Ragazzon; Felix Beuschlein; Rossella Libé; Aurélien de Reyniès; Jérôme Bertherat
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

8.  Feminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia.

Authors:  Anjana Harnoor; R Lee West; Fiona J Cook
Journal:  Case Rep Endocrinol       Date:  2012-06-26

9.  Current and emerging therapeutic options in adrenocortical cancer treatment.

Authors:  Antonio Stigliano; Lidia Cerquetti; Camilla Sampaoli; Barbara Bucci; Vincenzo Toscano
Journal:  J Oncol       Date:  2012-08-14       Impact factor: 4.375

10.  Repeated resections for liver metastasis from primary adrenocortical carcinoma: A case report.

Authors:  Ryosuke Nakano; Daisuke Satoh; Hirochika Nakajima; Yuri Yoshimura; Hisanobu Miyoshi; Kazuhiro Yoshida; Hiroyoshi Matsukawa; Shigehiro Shiozaki; Kouichi Ichimura; Masazumi Okajima; Motoki Ninomiya
Journal:  Int J Surg Case Rep       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.